Association Between Atherogenic Index of Plasma and Atherogenic Coefficient and in-Stent Restenosis After Drug-eluting Stent Implantation for Stable Coronary Artery Disease
-
Published:2023-02-01
Issue:1
Volume:24
Page:76-82
-
ISSN:2619-9793
-
Container-title:Istanbul Medical Journal
-
language:
-
Short-container-title:Istanbul Med J
Author:
Yüksel YasinORCID,
Yıldız CennetORCID,
Ayça BurakORCID,
Katkat FahrettinORCID,
Efe Süleyman ÇağanORCID,
Karabulut DilayORCID,
Turhan Çağlar Fatma NihanORCID
Publisher
Galenos Yayinevi
Reference25 articles.
1. 1. Sclofmitz E, Iantorno M, Waksman R. Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review. Circ Cardiovasc Interv 2019; 12: e007023.
2. Incidence and risk factors of in-stent restenosis after percutaneous coronary intervention in patients from southern China;Li;Eur J Med Res,2022
3. Factors Influencing Stent Restenosis After Percutaneous Coronary Intervention in Patients with Coronary Heart Disease: A Clinical Trial Based on 1-Year Follow-Up;Cheng;Med Sci Monit,2019
4. 4. Wang P, Qiao H, Wang R, Hou R, Guo J. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do BMC Cardiovasc Disord 2020; 20: 510.
5. The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index;Çelik;J Saudi Heart Assoc,2021